Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dittadi

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
How CA 125 is used in the routine follow-up of ovarian cancer: a survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
British Journal of Cancer|January 1, 1993
Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissueR Dittadi, P M Donisi, A Brazzale, et al.
Anticancer Research|November 1, 1992
Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parametersR Dittadi, P M Donisi, A Brazzale, et al.
The International Journal of Biological Markers|July 29, 1998
Impact of steroid receptors, pS2 and cathepsin D on the outcome of N+ postmenopausal breast cancer patients treated with tamoxifenR Dittadi, E Biganzoli, P Boracchi, et al.
The International Journal of Biological Markers|July 27, 2001
Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartmentsR Dittadi, S Meo, F Fabris, et al.
The International Journal of Biological Markers|July 1, 1996
Cathepsin D versus other prognostic factors in breast cancer. Results and controversies of a multicenter study on 2575 casesD Pelizzola, M Gion, A Paradiso, et al.
Cell Proliferation|July 1, 1996
c-erbB-2/neu protein expression, DNA ploidy and S phase in breast cancerR Dittadi, F Calderazzo, A Cabrelle, et al.
Anticancer Research|March 1, 1997
ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative methodR Dittadi, A Brazzale, G Pappagallo, et al.
Gastroenterology|June 1, 1988
Tumor marker radioimmunoassays in gastric juice. Methodologic drawbacks due to pH variationsM Gion, R Dittadi, G Munegato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancerM L Disis, S M Pupa, J R Gralow, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
How CA 125 is used in the routine follow-up of ovarian cancer: a survey of 29 Italian hospitalsM Gion, P Barioli, A Ponti, et al.
British Journal of Cancer|January 1, 1993
Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissueR Dittadi, P M Donisi, A Brazzale, et al.
Anticancer Research|November 1, 1992
Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parametersR Dittadi, P M Donisi, A Brazzale, et al.
The International Journal of Biological Markers|July 29, 1998
Impact of steroid receptors, pS2 and cathepsin D on the outcome of N+ postmenopausal breast cancer patients treated with tamoxifenR Dittadi, E Biganzoli, P Boracchi, et al.
The International Journal of Biological Markers|July 27, 2001
Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartmentsR Dittadi, S Meo, F Fabris, et al.
The International Journal of Biological Markers|July 1, 1996
Cathepsin D versus other prognostic factors in breast cancer. Results and controversies of a multicenter study on 2575 casesD Pelizzola, M Gion, A Paradiso, et al.
Cell Proliferation|July 1, 1996
c-erbB-2/neu protein expression, DNA ploidy and S phase in breast cancerR Dittadi, F Calderazzo, A Cabrelle, et al.
Anticancer Research|March 1, 1997
ErbB2 assay in breast cancer: possibly improved clinical information using a quantitative methodR Dittadi, A Brazzale, G Pappagallo, et al.
Gastroenterology|June 1, 1988
Tumor marker radioimmunoassays in gastric juice. Methodologic drawbacks due to pH variationsM Gion, R Dittadi, G Munegato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancerM L Disis, S M Pupa, J R Gralow, et al.
Pageof 5